AUPH · Aurinia Pharmaceuticals Inc. · Documents
$16.74
+0.25 (+1.52%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$2.20B
Shares
133.05M
Volume · Oct 20
198.96K
Avg daily vol (3M)
966.28K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2023-02-28 | — | |
| 10-K | — | 2023-02-28 | 2022-12-31 | |
| 8-K | — | 2023-01-27 | 2023-01-24 | |
| 8-K | — | 2023-01-09 | 2023-01-06 | |
| 8-K | — | 2023-01-03 | — | |
| 10-Q | — | 2022-11-03 | 2022-09-30 | |
| 8-K | — | 2022-11-03 | — | |
| 8-K | — | 2022-10-21 | 2022-10-17 | |
| 8-K | — | 2022-09-19 | — | |
| 10-Q | — | 2022-08-04 | 2022-06-30 | |
| 8-K | — | 2022-08-04 | — | |
| 8-K | — | 2022-07-15 | — | |
| 8-K | — | 2022-05-20 | 2022-05-17 | |
| 10-Q | — | 2022-05-10 | 2022-03-31 | |
| 8-K | — | 2022-05-10 | — | |
| DEF 14A | — | 2022-04-18 | — | |
| 10-K | — | 2022-02-28 | 2021-12-31 | |
| 8-K | — | 2022-02-28 | — | |
| 8-K/A | — | 2022-01-07 | 2021-12-09 | |
| 8-K | — | 2021-12-09 | — | |
| 10-Q | — | 2021-11-03 | 2021-09-30 | |
| 8-K | — | 2021-11-03 | — | |
| 8-K/A | — | 2021-09-17 | 2021-06-07 | |
| 8-K | — | 2021-08-17 | — | |
| 10-Q | — | 2021-08-05 | 2021-06-30 | |
| 8-K | — | 2021-08-05 | — | |
| 8-K | — | 2021-07-19 | 2021-07-16 | |
| 8-K | — | 2021-06-25 | — | |
| 8-K | — | 2021-06-17 | 2021-06-14 | |
| 8-K | — | 2021-06-10 | 2021-06-07 | |
| DEF 14A | — | 2021-05-10 | — | |
| 10-Q | — | 2021-05-06 | 2021-03-31 | |
| 8-K | — | 2021-05-06 | — | |
| 10-K/A | — | 2021-04-30 | 2020-12-31 | |
| 8-K | — | 2021-04-27 | — | |
| 8-K | — | 2021-02-24 | — | |
| 10-K | — | 2021-02-24 | 2020-12-31 | |
| 8-K | — | 2021-01-25 | — | |
| 6-K | — | 2020-12-30 | — | |
| 6-K | — | 2020-12-21 | 2020-12-17 | |
| 6-K | — | 2020-12-16 | 2020-12-15 | |
| 6-K | — | 2020-11-20 | — | |
| 6-K | — | 2020-11-10 | 2020-09-30 | |
| 6-K | — | 2020-11-10 | — | |
| 6-K | — | 2020-11-09 | — | |
| 6-K | — | 2020-11-02 | — | |
| 6-K | — | 2020-10-29 | 2020-10-27 | |
| 6-K | — | 2020-10-22 | — | |
| 6-K | — | 2020-10-14 | — | |
| 6-K | — | 2020-10-02 | — |
Showing 51–100 of 124 filings
Key facts
CIK
1600620
CUSIP
05156V102
13F (30d)
19 filings
19 filers
Visit website
Investor relations